Teon Therapeutics Completes $30 Million Series A Financing

24 Feb, 2021

Teon Therapeutics Completes $30 Million Series A Financing
Photo by Sean Pollock on Unsplash

– Teon Therapeutics completed a $30m Series A financing.
– The financing was led by Oceanpine Capital with participation from additional new investors Oriza Ventures, Lifespan Investments, and former Gilead senior executives.
– All existing investors also participated in the financing round including Northern Light Venture Capital, Kaitai Capital and Oriental Fortune Capital.
– The funds will be used to advance the company’s lead A2BR-selective antagonist TT-702 into the clinic as well as to build the company’s pipeline.

North America Pharmaceuticals

Related Posts

ReCode Therapeutics Raises Oversubscribed Series B Financing Round of $80 Million

ReCode Therapeutics Raises Oversubscribed Series B Financing Round of $80 Million

21 Oct, 2021
Zerigo Health Raises $43 Million in Series B Funding to Drive Adoption of the Industry’s Only Connected Light Therapy Solution to Treat Chronic Skin Conditions

Zerigo Health Raises $43 Million in Series B Funding to Drive Adoption of the Industry’s Only Connected Light Therapy Solution to Treat Chronic Skin Conditions

21 Oct, 2021
Via Separations Raises Oversubscribed $38 Million Series B Led by NGP ETP to Transform Industrial Energy Use

Via Separations Raises Oversubscribed $38 Million Series B Led by NGP ETP to Transform Industrial Energy Use

21 Oct, 2021
Superplastic raises $20M to expand its cartoon influencer universe

Superplastic raises $20M to expand its cartoon influencer universe

21 Oct, 2021

Crunchbase icon

Content report

The following text will be sent to our editors:

Send